Mirum Pharmaceuticals Inc.
MIRM | NASDAQ
$91.36
-$0.64 (-0.70%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.65B | -798.84M | -23.36M | -41.42M | -58.56M | -77.34M | -87.94M | -99.81M | -109.16M | -158.56M | -163.42M | -164.19M | -176.31M | -129.19M | -135.67M | -41.69M | -53.09M | -70.06M | -83.99M | -178.74M | -153.14M | -132.49M |
Depreciation & Amortization | 32.82M | 25.07M | 24.24M | 24.23M | 24.22M | 24.02M | 23.63M | 23.07M | 19.67M | 15.16M | 10.83M | 6.66M | 5.1M | 4.47M | 3.57M | 2.68M | 1.76M | 1.23M | 975K | 703K | 680K | 652K |
Stock-Based Compensation | 140.13M | 91.82M | 71.42M | 65.65M | 59.43M | 52.8M | 48.44M | 44.91M | 41.39M | 37.91M | 35.02M | 32.2M | 30.55M | 29.01M | 27.01M | 25.68M | 26.36M | 24.36M | 23.09M | 21.1M | 17.12M | 15.27M |
Other Working Capital | 107.7M | 50M | -13.32M | -17.1M | -14.18M | -7.32M | -3.13M | -4.26M | -2.26M | -4.42M | -5.05M | -5.87M | -6.39M | -3.43M | -4.51M | -5.19M | -4.42M | -6.3M | -5.67M | -4.32M | -3.34M | -3.31M |
Other Non-Cash Items | 859.03M | 417.18M | 3.24M | 3.63M | 4.68M | 6.33M | 3.6M | 17.2M | 15.67M | 64.61M | 69.26M | 57.46M | 61.17M | 12.94M | 12.58M | -94.55M | -93.97M | -90.23M | -90.58M | 14.64M | 10.43M | 4.45M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.58M | -6.58M | -5.49M | -5.49M | 1.09M | 764K | -939K | -939K | -939K |
Change in Working Capital | 162.36M | 93.8M | -19.72M | -7.39M | -20.77M | -12.65M | 22.59M | 13.41M | 9M | 3.93M | -22.64M | -20.73M | -16.91M | -9.89M | -21.05M | -5.64M | -2.77M | -13.61M | 16.98M | 7.34M | 6.71M | 17.13M |
Operating Cash Flow | -456.03M | -170.98M | 55.83M | 44.69M | 9M | -6.85M | 10.33M | -1.23M | -23.43M | -36.96M | -70.94M | -88.6M | -96.4M | -99.24M | -120.14M | -119.01M | -127.19M | -147.22M | -132.76M | -135.89M | -119.14M | -95.93M |
Capital Expenditures | -2.14M | -1.58M | -954K | -374K | -10.37M | -21.02M | -20.99M | -25.97M | -15.79M | -5.08M | -20.11M | -15.35M | -15.37M | -15.32M | -278K | -19.04M | -19.04M | -19.02M | -19.02M | -49K | -77K | -130K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -23.99M | -23.99M | -42.99M | -42.99M | -19M | -21M | -42.78M | -42.78M | -42.78M |
Purchase of Investments | -262.77M | -98.7M | -97.43M | -97.41M | -92.15M | -122.55M | -89.03M | -77.54M | -61.94M | -4.89M | -27.33M | -27.33M | -144.84M | -154.77M | -132.32M | -151.3M | -83.51M | -114.65M | -198.03M | -201.63M | -189.88M | -157.94M |
Sales Maturities Of Investments | 125.56M | 90.88M | 74.43M | 73.46M | 62.39M | 37.33M | 19.89M | 10.75M | 33M | 88.5M | 153M | 177M | 185M | 168.3M | 140.3M | 151.3M | 160.8M | 143.5M | 157.6M | 137.25M | 108.86M | 129.4M |
Other Investing Acitivies | -35M | n/a | n/a | n/a | -10M | -20M | -20M | -20M | -222.76M | -212.76M | -227.76M | -227.76M | -15M | 8.99M | 23.99M | 150.99M | 150.99M | 127M | 129M | 42.78M | 42.78M | 42.78M |
Investing Cash Flow | -184.35M | -19.39M | -23.95M | -24.32M | -40.13M | -106.25M | -90.13M | -92.77M | -257.49M | -134.23M | -107.2M | -78.44M | 24.79M | -1.79M | 7.7M | 88.97M | 166.26M | 117.83M | 48.55M | -64.42M | -81.1M | -28.67M |
Debt Repayment | 198.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 112.61M | 112.61M | 112.61M | 112.61M | n/a | n/a | n/a | n/a | 64.57M | 64.57M | 64.57M | 64.57M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.94M | 6.7M | 6.7M | 5.21M | 3.22M | -1.83M | -493K | 1.72M | 1.65M | 1.94M | 600K | -440K | 49.27M | 49.1M | 49.1M |
Financial Cash Flow | 776.69M | 303.86M | 40.14M | 36.48M | 24.25M | 22.85M | 17.7M | 14.14M | 217.4M | 324.82M | 336.6M | 334.49M | 213.43M | 103.97M | 109.09M | 110.03M | 24.31M | 84.98M | 73.47M | 207.36M | 209.11M | 143.22M |
Net Cash Flow | 132.08M | 114.14M | 75.24M | 59.11M | -4.89M | -90.6M | -63.4M | -79.67M | -63.73M | 153.42M | 158.32M | 167.3M | 141.96M | 3.15M | -3.34M | 79.92M | 63.33M | 55.6M | -10.75M | 7.07M | 8.9M | 18.64M |
Free Cash Flow | -458.17M | -172.55M | 54.87M | 44.32M | -1.37M | -27.87M | -10.67M | -27.2M | -39.22M | -42.04M | -91.05M | -103.95M | -111.77M | -114.56M | -120.41M | -138.05M | -146.23M | -166.24M | -151.78M | -135.94M | -119.22M | -96.06M |
Adj. Free Cash Flow | -598.3M | -264.38M | -16.55M | -21.33M | -60.8M | -80.67M | -59.11M | -72.11M | -80.61M | -79.95M | -126.08M | -136.15M | -142.32M | -143.57M | -147.42M | -163.73M | -172.59M | -190.6M | -174.87M | -157.04M | -136.33M | -111.33M |
Maintenance CapEx | -1.35M | -664K | n/a | n/a | -8.55M | -17.79M | -17.79M | -20.74M | -12.19M | -2.96M | -17.08M | -14.12M | -14.12M | -14.12M | n/a | -17.44M | -17.44M | -17.44M | -17.44M | -31K | -77K | -130K |
Growth CapEx | -787K | -913K | -954K | -374K | -1.82M | -3.23M | -3.21M | -5.23M | -3.6M | -2.12M | -3.03M | -1.23M | -1.25M | -1.2M | -278K | -1.6M | -1.6M | -1.58M | -1.58M | -18K | n/a | n/a |
Owner Earnings | -457.38M | -171.64M | 55.83M | 44.69M | 444.16K | -24.63M | -7.46M | -21.97M | -35.62M | -39.92M | -88.02M | -102.72M | -110.52M | -113.36M | -120.14M | -136.45M | -144.63M | -164.66M | -150.2M | -135.92M | -119.22M | -96.06M |
Add to Watchlist
Select watchlists to add or remove MIRM